Tamar GrossmanVP, Global Head of RNA & Targeted Therapeutics at Johnson & JohnsonSpeaker
Agenda Sessions
Round Table: Session 1
, 09:05View SessionRound Table: Session 2
, 09:50View SessionKeynote Panel: RNA Medicines 2.0
, 16:20View Session